Compare ARK Genomic Revolution ETF (ARKG) vs Lucid Group Inc (LCID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Lucid Group Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Lucid Group Inc trades at $5.52 (market cap $2.17B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Lucid Group Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | LCID | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $31.30 |
52-Week Low | $23.09 | $4.70 |
Market Cap | — | $2.17B |
Enterprise Value | — | $4.63B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Lucid Group (LCID) trades at $5.55, down 4.8% on the day, reflecting persistent bearish technical signals and fundamental challenges. The company continues to report significant losses, with a net income margin of -239.81% and negative cash flow from operations of $2.93B in 2025. Recent news highlights shareholder dilution concerns and multiple class-action lawsuits, adding to investor uncertainty.
The outlook remains highly speculative with substantial execution and liquidity risks, though a consensus analyst price target of $11.75 suggests potential upside if the company can achieve scale and improve profitability. High cash burn and competitive pressures in the EV market present significant headwinds for near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →
